CSTL vs PSA · rev $187.2M vs rev $1.23B
Castle Biosciences Inc (CSTL) versus PSA (PSA) — a side-by-side from cached financials, not a winner call.
Castle Biosciences Inc (CSTL) is a diagnostics & research company listed on US.
PSA (PSA) common stock.
Latest reported CSTL revenue for 2026-06-30 was $187.2M. Net income was -$16.6M. CSTL currently screens at market cap $570.2M.
Latest reported PSA revenue for 2026-06-30 was $1.23B. Net income was $500.0M. Revenue was up 1.2% from 2026-03-31 to 2026-06-30. PSA currently screens at market cap $0.
CSTL currently screens at market cap $570.2M. PSA currently screens at market cap $0.
Not investment advice. Open the CSTL and PSA stock pages for the full models.
Not investment advice.